Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)

Gynecologic Oncology

Volumn 100, Issue 2, 2006, Pages 300-307

  Wimberger, Pauline ^a   Lehmann, Nils ^a   Kimmig, Rainer ^a   Burges, Alexander ^b   Meier, Werner ^c   Hoppenau, Berit ^a   Du Bois, Andreas ^d  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Children s Hospital   (Germany)

^d DR HORST SCHMIDT KLINIKEN   (Germany)

Author keywords

Age; Ovarian neoplasm; Prognostic factor; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GROUPS BY AGE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; METHODOLOGY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVARY CANCER; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PACLITAXEL; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 30444441623     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.08.029     Document Type: Article

References (43)

1. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland: Krebs in Deutschland, 3. erw. Aufl., Saarbrücken; 2002.
2. G. Omura, J.A. Blessing, C.E. Ehrlich, A. Miller, E. Yordan, and W.T. Creasman A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecological Oncology Group Study Cancer 57 1986 1725 1730
3. W.P. McGuire, W.J. Hoskins, M.F. Brady, P.R. Kucera, E. Partidge, and K. Look Cyclophospamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer N. Engl. J. Med. 334 1996 1 6
4. M.J. Piccart, K. Bertelsen, K. James, J. Cassidy, C. Mangioni, and E. Simousen Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three years results J. Natl. Cancer Inst. 92 2000 699 708
5. A. Du Bois, H.J. Lück, W. Meier, H.P. Adams, V. Möbus, and S. Costa A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer J. Natl. Cancer Inst. 95 2003 1320 1330
6. R.F. Ozols, B.N. Bundy, B.E. Greer, J.M. Fowler, D. Clarke-Pearson, and R.A. Burger Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer. A Gynecologic Oncology Group Study J. Clin. Oncol. 21 2003 3194 3200
7. Interdisciplinary Guidelines of the German Cancer Association and the German Association of Gynecology and Obstetrics; 2003 [www.ago-ovar.de/ leitlinien/leitlinien.html].
8. R.E. Bristow, R.S. Tomacruz, D.K. Armstrong, E.L. Trimble, and F.J. Montz Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J. Clin. Oncol. 20 2002 1248 1259
9. S.M. Eisenkop, N.M. Spirtos, R.L. Friedman, W.C. Lin, A.L. Pisani, and S. Pertic Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study Gynecol. Oncol. 90 2003 390 396
10. A. Du Bois, J. Rochon, C. Lamparter, and J. Pfisterer The quality assurance program of the AGO Organkommission OVAR (QS-OVAR): pattern of care and reality in Germany in 2001 Zentralbl. Gynaekol. 127 2005 9 17
11. S.M. Eisenkop, and N.M. Spirtos The relative importance of surgical training and laboratory research in a gynecologic oncology fellowship Int. J. Gynecol. Cancer 14 2004 23 34
12. S.M. Eisenkop, and N.M. Spirtos Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival? Gynecol. Oncol. 82 2001 435 441
13. S.M. Eisenkop, R.L. Friedman, and H.J. Wang Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study Gynecol. Oncol. 69 1998 103 108
14. J.D. Wright, T.J. Herzog, and M.A. Powell Morbidity of cytoreductive surgery in the elderly Am. J. Obstet. Gynecol. 190 2004 1398 1400
15. C. La Vecchia, F. Lucchini, and E. Negri Trends of cancer mortality in Europe 1955-89; breast and genital sites Eur. J. Cancer 28 1992 927 998
16. M.A. Silverman, and J.D. Temple Cancer in the elderly patient. Unique aspects of presentation, management and screening J. Fla. Med. Assoc. 79 1992 89 92
17. S. Franceschi, and C. La Vecchia Cancer epidemiology in the elderly Crit. Rev. Oncol. Hematol. 39 2001 219 226
18. A. Jemal, T. Murray, A. Samuels, A. Ghafoor, E. Ward, and M.J. Thun Cancer statistics 2003 CA Cancer J. Clin. 53 2003 5 26
19. M. Gol, U. Saygili, B. Saatli, T. Uslu, and O. Erten Should advanced age alone be considered a contraindication to systemic lymphadenectomy in gynecologic oncologic patients? A university hospital experience in Turkey Int. J. Gynecol. Cancer 14 2004 508 514
20. S. Monfardini, L. Ferrucci, L. Fratino, I. del Lungo, D. Serraino, and V. Zugonel Validation of a multidimensional evaluation scale for use in elderly cancer patients Cancer 77 1996 395 401
21. R.D. Hightower, H.N. Nguyen, H.E. Averette, W. Hoskins, T. Harrison, and A. Stere A national survey of ovarian carcinoma IV: patterns of care and related survival for older patients Cancer 73 1994 377 383
22. International Federation of Gynecology and Obstetrics Changing in definitions of clinical staging for carcinoma of the cervix and ovary Am. J. Obstet. Gynecol. 156 1987 263 264
23. V. Hess, R. A'Hern, N. Nasiri, D.M. King, P.R. Blake, and D.P. Barton Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment J. Clin. Oncol. 22 2004 1040 1044
24. D.S. Chi, J.B. Liao, L.F. Leon, E.S. Venkatraman, M.L. Hensley, and D. Bhaskara Identification of prognostic factors in advanced epithelia ovarian carcinoma Gynecol. Oncol. 82 2001 532 537
25. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J. Am. Stat. Assoc. 53 1958 457 481
26. D.R. Cox, and D. Oakes Analysis of survival data 1984 Chapman and Hall London, UK 309 346
27. P. Harter, C. Schade-Brittinger, A. Belau, J. Sehouli, S. Loibl, and H.J. Lueck AGO-OVAR 14: a retrospective study evaluating the reasons for non-participating in trials in patients with ovarian cancer (OC) treated in coordinating centers of the AGO Ovarian Cancer Study Group Proc. Am. Soc. Clin. Oncol. 23 2004 [Abstract 5081]
28. L.A.G. Ries M.P. Eisner C.L. Kosary B.F. Hankey B.A. Miller L. Clegg SEER cancer statistics review, 1973-1999 2002 National Cancer Institute Bethesda, MD http://seer.cancer.gov/csr/1973_1999/
29. A. Berchuck, M. Kohler, M.P. Boente, G.C. Rodriguez, R.S. Whitaker, and R.C. Bast Jr. Growth regulation and transformation of ovarian epithelium Cancer 71 1993 545 551
30. R. Yancik Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality Cancer 71 1993 517 523
31. S. Pignata, and J.B. Vermorken Ovarian cancer in the elderly Crit. Rev. Oncol. Hematol. 49 2004 77 86
32. A.J. Nordin, D.J. Chinn, I. Moloney, R. Nalk, A. de Barros Lopes, and J.M. Monaghan Do elderly cancer patients care about cure? Attitudes to radical gynecologic oncology surgery in the elderly Gynecol. Oncol. 81 2001 447 455
33. C.V. Kirschner, T.M. DeSerto, and J.H. Isaacs Surgical treatment of the elderly patients with gynaecologic cancer Surg. Gynecol. Oncol. 81 2001 447 455
34. F.G. Lawton, and N.F. Hacker Surgery for invasive gynaecologic cancer in the elderly female population Obstet. Gynecol. 76 1990 287 289
35. S.G. Levrant, R.G. Fruchter, and M. Maiman Radical hysterectomy for cervical cancer: morbidity and survival in relation to weight and age Gynecol. Oncol. 45 1992 317 322
36. I.D. Karanikas, T.D. Liakakos, S.S. Koundorakis, S.B. Tzorakis, and S.S. Dendrinos Emergency operations in the elderly: management and outcome Int. Surg. 81 1996 158 166
37. P. Niettinen, P. Pasanen, P.A. Salomen, J. Lahitinene, and E. Alahva The outcome of elderly patients after operation for acute abdomen Ann. Chir. Gynaecol. 85 1996 11 18
38. T. Susini, G. Scambia, P.A. Margariti, R. Giannice, P. Signorile, and P. Benedetti-Panici Gynaecologic oncologic surgery in the elderly: a retrospective analysis of 213 patients Gynecol. Oncol. 75 1999 437 443
39. D.S. Alberts, S. Dahlberg, S.J. Green, D. Garcia, E.V. Hannigan, and L. O'Tolle Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin- cyclophosphamide in stage III (suboptimal) and IV ovarian cancer Cancer 71 1993 618 627
40. L. Balducci, and C. Beghe The application of the principles of geriatric to the management of the older persons with cancer Crit. Rev. Oncol. Hematol. 35 2000 147 154
41. L. Repetto, A. Venturino, M. Vercelli, W. Gianni, V. Biancardi, and C. Casella Performance status and comorbidity in elderly cancer patients without neoplastic conditions Cancer 82 1998 760 851
42. L. Balducci, and M. Extermann Cancer and aging. An evolving panorama Hematol./Oncol. Clin. North Am. 14 2000 1 16
43. L. Repetto, L. Fratino, R.A. Audisio, A. Venturino, W. Gianni, and M. Vercelli Comprehensive geriatric assessment adds information to Eastern cooperative oncology group performance status in elderly cancer patients: an Italian group for geriatric oncology study J. Clin. Oncol. 20 2002 494 502